Glucose-insulin-potassium therapy in patients with STEMI [3]

JAMA

Volumn 299, Issue 20, 2008, Pages 2386-

  Arora, Rohit R ^a   Katragadda, Srikanth ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; POTASSIUM;

CLINICAL TRIAL; DOSE RESPONSE; DRUG MEGADOSE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REPERFUSION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; LETTER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 44349151847     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.299.20.jlt0528-c     Document Type: Letter

References (5)

1. Díaz R, Goyal A, Mehta SR, et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA. 2007;298(20):2399-2405.
2. Díaz R, Paolasso EA, Piegas LS, et al. Metabolic modulation of acute myocardial infarction: the ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation. 1998;98(21):2227-2234.
3. Krljanac G, Vasiljević Z, Radovanović M, et al. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy. Am J Cardiol. 2005;96(8):1053-1058.
4. Mehta SR, Yusuf S, Díaz R, et al. Effect of glucose-insulin- potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. JAMA. 2005;293(4):437-446.
5. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;26(1):57-65.